Cholestyramine for Oral Suspension
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
62135-937 -
Package NDC
62135-937-54 -
Application number
ANDA074562 -
SPL ID
f1d8692b-deb3-d55f-e053-2a95a90ae615 -
SPL set ID
80db0042-0c05-4509-8a6b-fa9f4783629a -
UNII
4B33BGI082 -
RxCUI
848943 -
RxCUI
1801279
What the source publishes
- Labeler
- Chartwell RX, LLC
- Active ingredients
- Cholestyramine for Oral Suspension
- Form
- POWDER
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cholestyramine for Oral Suspension",
"splId": "f1d8692b-deb3-d55f-e053-2a95a90ae615",
"labels": [
{
"setId": "80db0042-0c05-4509-8a6b-fa9f4783629a",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80db0042-0c05-4509-8a6b-fa9f4783629a",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=80db0042-0c05-4509-8a6b-fa9f4783629a"
}
],
"routes": [
"ORAL"
],
"labeler": "Chartwell RX, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "239.4 g in 1 CAN (62135-937-54)",
"package_ndc": "62135-937-54",
"identifierStatus": "well-formed",
"marketing_start_date": "20230103"
}
],
"productId": "62135-937_f1d8692b-deb3-d55f-e053-2a95a90ae615",
"useDomain": "unknown",
"dosageForm": "POWDER",
"productNdc": "62135-937",
"deaSchedule": null,
"genericName": "Cholestyramine for Oral Suspension",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CHOLESTYRAMINE",
"strength": "4 g/5.7g"
}
],
"applicationNumber": "ANDA074562",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "19960815",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000180292",
"N0000175365"
],
"upc": [
"0362135008567",
"0362135937546"
],
"unii": [
"4B33BGI082"
],
"rxcui": [
"848943",
"1801279"
],
"spl_set_id": [
"80db0042-0c05-4509-8a6b-fa9f4783629a"
],
"pharm_class_epc": [
"Bile Acid Sequestrant [EPC]"
],
"pharm_class_moa": [
"Bile-acid Binding Activity [MoA]"
],
"manufacturer_name": [
"Chartwell RX, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:62135-937_f1d8692b-deb3-d55f-e053-2a95a90ae615"